CD4 and influenza: As an experimental control, we also studied the reactivity of CD4 T cells against MP65 (Candida Albicans; C.ALB), MP1 (Influenza; H1N1) and SPIKE (SARS-CoV-2) in the AILD patients (Supplementary Data 1).